about
The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord InjuryPotentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression.Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative DiseasesDeubiquitinases (DUBs) and DUB inhibitors: a patent reviewProtein misfolding specifies recruitment to cytoplasmic inclusion bodiesSystems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases.Degradation of gamma secretase activating protein by the ubiquitin-proteasome pathway.Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutationNormal Molecular Specification and Neurodegenerative Disease-Like Death of Spinal Neurons Lacking the SNARE-Associated Synaptic Protein Munc18-1.Key Immune Events of the Pathomechanisms of Early Cardioembolic Stroke: Multi-Database Mining and Systems Biology Approach.Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1.Dynamics of an Active-Site Flap Contributes to Catalysis in a JAMM Family Metallo Deubiquitinase.Battling Alzheimer's Disease: Targeting SUMOylation-Mediated Pathways.α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.Drosophila Neuronal Injury Follows a Temporal Sequence of Cellular Events Leading to Degeneration at the Neuromuscular Junction.Proteolysis, synaptic plasticity and memory.The remarkable multivalency of the Hsp70 chaperones.Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain.New developments in RAN translation: insights from multiple diseases.Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72.Commentary: Immunochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases.iPTMnet: an integrated resource for protein post-translational modification network discovery.Co-expression Patterns between ATN1 and ATXN2 Coincide with Brain Regions Affected in Huntington's Disease.Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.Astrocyte Dysfunction Induced by Alcohol in Females but Not Males.Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.Nanoparticles Exacerbate Both Ubiquitin and Heat Shock Protein Expressions in Spinal Cord Injury: Neuroprotective Effects of the Proteasome Inhibitor Carfilzomib and the Antioxidant Compound H-290/51.A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders.Altered DNA Methylation Patterns Associated With Clinically Relevant Increases in PTSD Symptoms and PTSD Symptom Profiles in Military Personnel.Active Site Gate Dynamics Modulate the Catalytic Activity of the Ubiquitination Enzyme E2-25K.Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis.Mammalian TRIM67 Functions in Brain Development and Behavior.
P2860
Q26767879-89E1D3DF-4CA7-4F68-88DE-AF3C1C3217E4Q27301199-8134223C-DD1C-4D50-ABBC-01AB52D61EE0Q28070156-2B2246E2-8ABF-4A3F-BED8-9852E7088C6FQ28073686-E9273A7F-93E9-4A71-BAB7-DFEF8844AE14Q28834608-4EEC5D6B-97A3-4FBA-898D-26EF0142AF11Q30826780-86DCA0B3-2E18-478C-845C-365B097151B8Q31167311-68A9E36F-62CA-4B86-874B-E5EECE3EEBF1Q33576114-23D65921-337A-4FFD-BCDA-09363754C25BQ35417877-0CFC6099-0A62-44A0-8876-889E13DFBF1BQ35996880-4138A78E-FBDB-45AB-ACDA-9F0C82EAD735Q36456714-447A71F9-CD57-40A7-9B66-AD15FE4C7AB2Q36743527-96257790-3992-4EB4-AAF4-8DC83DBF302BQ36985668-13C34520-3FBC-4F95-B7DE-285FA19FCBFBQ37130380-E344460E-8A53-4FDB-8599-EA9230F03005Q38557970-245240CA-F17B-4EEB-96A8-740615CBACA1Q38669019-52F6D370-38D1-425C-BB63-01D48E55B180Q38948778-67B5A993-EC10-41CD-8AE2-F2ADCD7209CDQ38950862-5424BF95-CBE7-44CB-A472-3C08F7B66C89Q39144895-BCBEBCC4-036E-4DB7-B2C9-073A9331C075Q39193175-9BBD745B-8D25-46B7-AEBC-04D497E46F2DQ39213248-92D1F153-DB67-44D9-BAD3-6D69A5EF27F1Q39370811-E7152D96-A4C8-49A0-B642-704317648F44Q41893096-B73FE4B0-142D-4E9F-B76A-9DB6C57141DDQ46260198-67A23AB3-0650-46C2-BB3C-02EE5D1CCD94Q47099867-1EB20D61-4D8D-4BBC-8A64-E1D7FF618688Q47122754-3F5EBCC1-FBB2-4205-8468-9DA71EDAE163Q48122143-DB992D13-9B2E-4EEA-B26B-81FD11AA9561Q50023771-5FFFF8C4-4112-473B-9C2B-6E0FF269BE64Q50212589-65CAA60B-CD34-4C74-BF04-3D94399EA5D3Q50329951-3388B15B-D26F-423C-9E23-ED0EE445A549Q52668986-17DC3060-E4A9-4CB4-BC2A-54D99CF61B15Q55114669-D07DBFA9-244A-4FFD-B73C-A764CD9F7C6DQ55282282-CD4F0DC2-59D6-495E-BE29-AD4EE8D0FFB8Q55387038-1AF33F19-E54B-4B1D-9C56-013FA1A9F1EE
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Ubiquitin pathways in neurodegenerative disease.
@en
type
label
Ubiquitin pathways in neurodegenerative disease.
@en
prefLabel
Ubiquitin pathways in neurodegenerative disease.
@en
P2860
P356
P1476
Ubiquitin pathways in neurodegenerative disease.
@en
P2093
Graham Atkin
Henry Paulson
P2860
P356
10.3389/FNMOL.2014.00063
P577
2014-07-08T00:00:00Z